Small-Cap Sector Developments Covered for October 18

2 min read | October 18, 2024 04:02 PM AEDT | By Team Kalkine Media

Highlights:

  • Mako Gold Ltd has seen a substantial surge of over 83% following the announcement of a Bid Implementation Agreement with Aurum Resources.

  • Provaris Energy Ltd experienced a 47% increase after releasing a corporate presentation outlining its plans to develop supply chains to meet Europe’s 2030 emission targets.

  • Ovanti Ltd's share price skyrocketed by over 700%, reflecting significant market interest and momentum.

Mako Gold Ltd (ASX:MKG) has experienced a remarkable increase in its share price, surging over 83% to trade at $0.016 per share. This rise follows the announcement of a Bid Implementation Agreement with Aurum Resources, which aims to establish a growing exploration and development gold company in West Africa. The merger is further supported by an infusion of over $20 million in cash, earmarked for advancing flagship projects in the region.

Provaris Energy Ltd (ASX: PV1, OTC: GBBLF) also made headlines with a 47% increase in its share price, reaching $0.027 per share. This surge followed the release of the company’s corporate presentation, which detailed plans to develop scalable supply chains designed to support Europe’s ambitious 2030 emission reduction targets. Despite a slight pullback today, the overall market reaction indicates strong interest in Provaris's initiatives.

Solis Minerals Ltd (ASX: SLM, TSX-V: SLMN, OTCQB: SLMFF) recorded a 50% increase, bringing its share price to $0.125 after the completion of a magnetometry survey at its Cinto project. The survey identified magnetic anomalies that could indicate promising mineral deposits. Additionally, Solis released an updated investor presentation, disclosing $2.7 million in cash as of August 30, further bolstering its financial position.

Ovanti Ltd saw an extraordinary share price increase of over 700%, rising from $0.003 to $0.02 by the end of the week, highlighting significant market enthusiasm.

Finally, Inhalerx Ltd (ASX:IRX) doubled its share price to $0.035 following the announcement of a $38.5 million funding agreement with Clendon Biotech Capital. This funding will cover the costs associated with the Phase 1 and 2 clinical development of its key projects, demonstrating a strong commitment to advancing its pipeline.

The recent movements in these companies reflect a dynamic market environment with robust investor interest in exploration and sustainable development initiatives.

 

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.